270 related articles for article (PubMed ID: 24440286)
1. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
2. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.
Cufi P; Dragin N; Weiss JM; Martinez-Martinez P; De Baets MH; Roussin R; Fadel E; Berrih-Aknin S; Le Panse R
Ann Neurol; 2013 Feb; 73(2):281-93. PubMed ID: 23280437
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
[TBL] [Abstract][Full Text] [Related]
4. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
5. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
6. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
8. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
10. Gm allotypes in myasthenia gravis.
Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
[TBL] [Abstract][Full Text] [Related]
11. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
12. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
13. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
14. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
15. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of myasthenia gravis.
Marx A; Wilisch A; Schultz A; Gattenlöhner S; Nenninger R; Müller-Hermelink HK
Virchows Arch; 1997 May; 430(5):355-64. PubMed ID: 9174625
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues.
Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
